Back

Sage Therapeutics Quote, Financials, Valuation and Earnings

$50 trade to make today with huge potential!

Click here to access my #1 options strategy for overnight wins starting with $50!

Sell

SAGE
Sage Therapeutics

Last Price:

13.67

Seasonality Move:

7.64%

7 Day Trial

ALL ACCESS PASS

$ 7

9,530x the last time this happened

Here's what our expert says you should buy before April 14.

Sage Therapeutics Price Quote

$13.67

-0.02 (0.66%)

(Updated: April 27, 2024 at 6:19 AM ET)

Sage Therapeutics Key Stats

Sell

Sage Therapeutics (SAGE) is a Sell

Day range:

$13.38 - $13.91

52-week range:

$10.92 - $59.99

Dividend yield:

P/E ratio:

0.00

P/S ratio:

9.01

P/B ratio:

1.17%

Volume:

1.5M

Avg. volume:

1.1M

1-year change:

-70.88%

Market cap:

$823.9M

Revenue:

$86.5M

EPS:

$-8.39

How Much Does Sage Therapeutics Make?

How Much Are Sage Therapeutics's Sales Annually?
SAGE Revenues are $86.5M
How Much Profit Does Sage Therapeutics's Make A Year?
SAGE net income is -$541.5M

Is Sage Therapeutics Growing As A Company?

What Is Sage Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.4%
What Is Sage Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Sage Therapeutics Stock Price Performance

Did Sage Therapeutics Stock Go Up Last Month?
Sage Therapeutics share price went down by -26.48% last month
Did SAGE's Share Price Rise Over The Last Year?
SAGE share price fell by -70.88% over the past 1 year

What Is Sage Therapeutics 52-Week High & Low?

What Is Sage Therapeutics’s 52-Week High Share Price?
Sage Therapeutics has traded as high as $59.99 over the past 52 weeks
What Is Sage Therapeutics’s 52-Week Low Share Price?
Sage Therapeutics has traded as low as $10.92 over the past 52 weeks

Sage Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sage Therapeutics?

How Much Debt Does Sage Therapeutics Have?
Total long term debt quarterly is $0
How Much Cash Does Sage Therapeutics Have?
Cash and short term investments quarterly total is $717M
What Is Sage Therapeutics’s Book Value Per Share?
Book value per share is 11.73

Is Sage Therapeutics Cash Flow Positive?

What Is SAGE Cash Flow From Operations?
Cash flow from operations (TTM) is -$424.7M
What Is Sage Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $4.9M
What Is Sage Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $387.5M

Sage Therapeutics Return On Invested Capital

Is Management Doing A Good Job?
SAGE return on invested capital is -56.67%
What Is Sage Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -51.32%
What Is SAGE Return On Equity?
ROE is a measure of profitability and is -56.67%

Sage Therapeutics Earnings Date & Stock Price

What Is Sage Therapeutics's Stock Price Today?
A single share of SAGE can be purchased today for 13.69
What Is Sage Therapeutics’s Stock Symbol?
Sage Therapeutics trades on the nasdaq under the ticker symbol: SAGE
When Is Sage Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Sage Therapeutics is scheduled on August 7, 2024
When Is SAGE's next ex-dividend date?
Sage Therapeutics's next ex-dividend date is April 28, 2024
How To Buy Sage Therapeutics Stock?
You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Sage Therapeutics Competitors

Who Are Sage Therapeutics's Competitors?
Below is a list of companies who compete with Sage Therapeutics or are related in some way:
- ADMA Biologics Inc (ADMA)
- Biogen Inc (BIIB)
- Perspective Therapeutics Inc (CATX)
- Ligand Pharmaceuticals Inc (LGND)
- Vanda Pharmaceuticals Inc (VNDA)

Sage Therapeutics Dividend Yield